Abren la puerta para utilizar una nueva vía para el desarrollo de medicamentos

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Un equipo internacional, liderado por la Universidad de Birmingham, en el Reino Unido, con participación del Instituto Hospital del Mar de Investigaciones Médicas, ha analizado cómo una proteína e...

Read more

Almirall: Hasta el 73% de los pacientes con dermatitis atópica tratados con lebrikizumab logran un aclaramiento de la piel de la cara o las manos

by Asebio

Almirall ha anunciado recientemente los resultados de un análisis secundario del programa en fase III (estudios ADvocate y ADhere) que ha demostrado que los pacientes tratados con lebrikizumab mejora...

Read more

ORYZON reports financial results and corporate update for quarter ended March 31, 2023

by Oryzon Genomics

Oryzon Genomics, S.A. a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the first ...

Read more

Palobiofarma announces the enrolment of the first three patients in the clinical study investigating the effects of its novel compound PBF-999 for the treatment of Prader-Willi Syndrome

by Palobiofarma

Palobiofarma S.L., a biopharmaceutical company dedicated to the discovery and development of innovative drugs, has enrolled the first three patients in a clinical study to investigate the potential of...

Read more

ORYZON to present trial in progress Phase Ib FRIDA study at the upcoming 2023 ASCO annual meeting

by Oryzon Genomics

Oryzon today announced the presentation of the trial in progress (TIP) FRIDA poster entitled Iadademstat in combination with gilteritinib for patients with mutated FLT3 relapsed/refractory acute myelo...

Read more

Una nueva vía para el tratamiento del cáncer de hígado infantil

by CIBEREHD-Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Han descubierto una posible vía para el tratamiento de los pacientes con hepatoblastoma, combinando la quimioterapia habitual con un fármaco actualmente en ensayos clínicos, el xentuzumab

Read more

A Spanish team presents the first pharmacological treatment able to improve cardiac function in stiff-heart syndrome

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

The study represents a major advance in the treatment of the disease. Although currently available treatments effectively prevent the accumulation of more amyloid fibrils and delay disease progression...

Read more

Clinical trials: the patient's perspective

by Sermes CRO

From the beginning of the development of any drug until it is available to patients and health professionals, its safety and efficacy must be studied and demonstrated. That is exactly what clinical t...

Read more

Pacientes con Parkinson, esquizofrenia, EPOC, diabetes o enfermedades raras, un pequeño ejemplo de quiénes se pueden beneficiar de la innovación incremental de los medicamentos

by Farmaindustria

A veces, la innovación farmacéutica se basa en una nueva forma de aplicación, con efectos más rápidos de actuación; en una mejora en la composición, que reduce los efectos adversos, o en un nue...

Read more

CRG teams up with Almirall to develop new preclinical models for non-melanoma skin cancer

by Centre for Genomic Regulation

This new collaboration comes from a call from AlmirallShare, the company's open innovation platform, to find innovative therapies for skin diseases

Read more

ORYZON to present positive preclinical efficacy data of ORY-4001 in Charcot-Marie-Tooth (CMT) disease at the 2023 Peripheral Nerve Society (PNS) Annual Meeting

by Oryzon Genomics

Oryzon announced today that it will present positive preclinical efficacy data of ORY-4001 in a CMT model at the 2023 Peripheral Nerve Society (PNS) Annual Meeting, which will be held June 17-20 at th...

Read more

International funding for IRBLleida's innovative Friedreich's Ataxia project

by IRB Lleida. Institut de Recerca Biomèdica

The US association FARA (Friedreich's Ataxia Research Alliance) has awarded a grant of 85,000 US dollars a project led by Jordi Tamarit Sumalla, professor at the University of Lleida and researcher i...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

The Dhx15 gene could be a target for dia...

by Fundació Clínic per a la Recerca Biomèdica

A study by the Clínic-IDIBAPS shows that silencing this gene reduces ...

Photos Stream